DXCM
Price
$75.46
Change
-$0.79 (-1.04%)
Updated
Aug 5 closing price
Capitalization
53.47B
78 days until earnings call
GKOS
Price
$88.06
Change
+$0.56 (+0.64%)
Updated
Aug 5 closing price
Capitalization
4.61B
84 days until earnings call
Interact to see
Advertisement

DXCM vs GKOS

Header iconDXCM vs GKOS Comparison
Open Charts DXCM vs GKOSBanner chart's image
DexCom
Price$75.46
Change-$0.79 (-1.04%)
Volume$5.63M
Capitalization53.47B
Glaukos
Price$88.06
Change+$0.56 (+0.64%)
Volume$1.76M
Capitalization4.61B
DXCM vs GKOS Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. GKOS commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a StrongBuy and GKOS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (DXCM: $75.46 vs. GKOS: $88.06)
Brand notoriety: DXCM and GKOS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 175% vs. GKOS: 171%
Market capitalization -- DXCM: $53.47B vs. GKOS: $4.61B
DXCM [@Medical Specialties] is valued at $53.47B. GKOS’s [@Medical Specialties] market capitalization is $4.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than GKOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 5 TA indicator(s) are bullish while GKOS’s TA Score has 5 bullish TA indicator(s).

  • DXCM’s TA Score: 5 bullish, 5 bearish.
  • GKOS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both DXCM and GKOS are a good buy in the short-term.

Price Growth

DXCM (@Medical Specialties) experienced а -15.55% price change this week, while GKOS (@Medical Specialties) price change was -6.08% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.19%. For the same industry, the average monthly price growth was -1.03%, and the average quarterly price growth was -3.43%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 23, 2025.

GKOS is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (-1.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($53.5B) has a higher market cap than GKOS($4.61B). DXCM YTD gains are higher at: -2.970 vs. GKOS (-41.270). DXCM has higher annual earnings (EBITDA): 917M vs. GKOS (-82.12M). DXCM has more cash in the bank: 2.72B vs. GKOS (295M). GKOS has less debt than DXCM: GKOS (384M) vs DXCM (2.59B). DXCM has higher revenues than GKOS: DXCM (3.62B) vs GKOS (315M).
DXCMGKOSDXCM / GKOS
Capitalization53.5B4.61B1,162%
EBITDA917M-82.12M-1,117%
Gain YTD-2.970-41.2707%
P/E Ratio106.11N/A-
Revenue3.62B315M1,150%
Total Cash2.72B295M923%
Total Debt2.59B384M676%
FUNDAMENTALS RATINGS
DXCM vs GKOS: Fundamental Ratings
DXCM
GKOS
OUTLOOK RATING
1..100
566
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10056
SMR RATING
1..100
4196
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
3263
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (81) in the Medical Specialties industry is in the same range as GKOS (93). This means that DXCM’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for DXCM (100). This means that GKOS’s stock grew somewhat faster than DXCM’s over the last 12 months.

DXCM's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for GKOS (96). This means that DXCM’s stock grew somewhat faster than GKOS’s over the last 12 months.

DXCM's Price Growth Rating (62) in the Medical Specialties industry is in the same range as GKOS (65). This means that DXCM’s stock grew similarly to GKOS’s over the last 12 months.

DXCM's P/E Growth Rating (32) in the Medical Specialties industry is in the same range as GKOS (63). This means that DXCM’s stock grew similarly to GKOS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMGKOS
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 13 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSLX16.030.06
+0.38%
NYLI Fiera SMID Growth Class C
MCLRX15.81N/A
N/A
BlackRock Advantage Large Cap Core Inv C
FMGKX16.03N/A
N/A
Fidelity Magellan K
DPWRX70.69N/A
N/A
BNY Mellon Worldwide Growth I
LMVOX28.37N/A
N/A
Lord Abbett Focused Small Cap Value F3

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with ISRG. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
-1.04%
ISRG - DXCM
44%
Loosely correlated
-1.32%
ALGN - DXCM
44%
Loosely correlated
+1.36%
SYK - DXCM
41%
Loosely correlated
-0.17%
BSX - DXCM
40%
Loosely correlated
-1.84%
BAX - DXCM
36%
Loosely correlated
+1.78%
More

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+0.64%
ISRG - GKOS
51%
Loosely correlated
-1.32%
ITGR - GKOS
49%
Loosely correlated
+0.83%
RDNT - GKOS
48%
Loosely correlated
-0.56%
NTRA - GKOS
48%
Loosely correlated
+2.60%
DXCM - GKOS
46%
Loosely correlated
-1.04%
More